Skip to main content

SB 350 (2018)


Establishes requirements for dispensing and substituting biological products by pharmacists. The bill defines biological products as, "a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of a disease or condition of human beings."

Bill Became Law?:
Status Detail:
Interim Study
Bill Sponsor:
Thank you to our sponsors and donors